FDA reevaluating vaginal mesh implants

The FDA says there is little evidence that the implants, used to strengthen vaginal tissue, improve pelvic organ prolapse and warns that patients are exposed to a number of serious risks. The agency releases an updated advisory after a rise in reported complications, and is calling for a reassessment.WASHINGTON – Following a spike in reported complications, the Food and Drug Administration released an updated advisory Wednesday about a surgical mesh implanted in women to strengthen vaginal tissue that can become weakened, especially after childbirth.

Read the whole article on LA Times - Science

More from LA Times - Science